BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 25, 2002
View Archived Issues
Coumarin-based compounds as leads for new antiviral agents for measles
Read More
Hemolink deemed not approvable by Canadian authorities
Read More
Atrix initiates phase II trial of low-dose oral interferon alfa product in oral warts
Read More
Isotechnika enters negotiations for drug development agreement
Read More
Encouraging phase I results reported for StreptAvax vaccine
Read More
Pegasys recommended for approval in E.U. for chronic hepatitis C
Read More
Vernalis presents annual progress review
Read More
Minimally invasive treatment for GERD safe and effective in long-term human trial
Read More
Potent, selective, orally active vasopressin V1b receptor antagonist characterized
Read More
Speedel enters agreement with Roche for new class of renin inhibitors
Read More
Angiogenic growth factor therapy evaluated for CAD in FIRST trial
Read More
Label change for Xenical cleared by CPMP
Read More
Efficacy, pharmacokinetic and exposure-response data discussed in Baltimore for pregabalin
Read More
Galanin: role in Alzheimer's disease
Read More
Remicade granted priority review as Crohn's disease monotherapy
Read More
Transition Therapeutics confirms efficacy of interferon combination therapy
Read More
Vfend receives marketing approval in Europe for the treatment of fungal infections
Read More
Seattle Genetics initiates phase I monoclonal antibody study
Read More
Antagonists of human 11CBy receptor claimed for diabetes, depression, etc.
Read More
Novel anticoagulants designed at 3-D
Read More
Sanofi-Synthelabo reports preparation and use of new benzimidazoles
Read More
New PDE5 inhibitors from Almirall Prodesfarma and their use
Read More
Recent patent covers Agouron's CDK inhibitors
Read More
Inhibitors of fatty acid synthase FabH under study at GSK
Read More